Pages that link to "Q26774768"
Jump to navigation
Jump to search
The following pages link to Panoptic clinical review of the current and future treatment of relapsed/refractory T-cell lymphomas: Cutaneous T-cell lymphomas (Q26774768):
Displaying 8 items.
- An overview of cutaneous T cell lymphomas (Q26740306) (← links)
- Systemic therapy for cutaneous T-cell lymphoma: who, when, what, and why? (Q30239965) (← links)
- Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth (Q42513461) (← links)
- A retrospective comparative outcome analysis following systemic therapy in Mycosis fungoides and Sezary syndrome (Q51484852) (← links)
- Monoclonal antibodies against cutaneous T-cell lymphomas (Q51803389) (← links)
- Novel phosphorylated TAK1 species with functional impact on NF-κB and β-catenin signaling in human Cutaneous T-cell lymphoma. (Q52365162) (← links)
- The underlying molecular mechanism and potential drugs for treatment in papillary renal cell carcinoma: A study based on TCGA and Cmap datasets (Q64255334) (← links)
- Systemic Treatment Options for Advanced-Stage Mycosis Fungoides and Sézary Syndrome (Q88153215) (← links)